Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone indicates caution and skepticism, with many discussions emphasizing the increased bleeding risks associated with aspirin, such as 'Aspiryna nawet w mniejszej dawce zwiększa ryzyko poważnego krwawienia,' and noting the lack of clear overall benefit, as reflected in phrases like 'Another nail in the coffin.' The tone and word choice suggest users are critically reflecting on the publication’s findings, but without deep engagement or broad impact.
Most discussions highlight the risks associated with aspirin use, especially bleeding, suggesting some skepticism about its benefits as a preventive measure.
There is moderate interest, as users are engaging with the topic mainly through sharing summaries and basic opinions without deep analysis.
The level of engagement appears limited; most contributions are reposts or brief comments without detailed analysis or personal input.
The overall influence of these discussions seems relatively low, likely affecting awareness more than policy or practice.
Aspiryna spełnia zarówno 1. jak i 2. kryterium, takich przykładów zresztą jest więcej. Aspiryna nawet w małej dawce zwiększa ryzyko poważnego krwawienia. Zresztą nie ma działającego leku bez działań niepożądanych. https://t.co/dh6a9cb50a
@JAMA_current AAS en prevención 1 no beneficio global, < riesgo de eventos CV, pero > riesgo de sangrado y sin efecto sobre riesgo de cáncer Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events https://t.co/yVPGMEFNCZ
Association of aspirin use for primary prevention with cardiovascular events and bleeding events: https://t.co/52QFxYK81e
Is it time to re-visit use of Aspirin in primary prevention? Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. | Cardiology | JAMA | JAMA Network https://t.co/qvA4TESpRv
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding EventsA Systematic... https://t.co/xMSGzA6ykS
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. - PubMed - NCBI https://t.co/vQ6oUpFDDN
Prof. Dr. Christoph Kleinschnitz from Essen explains current therapeutic strategies for patients with acute stroke. This discussion, held on July 14, 2025, includes insights on the impact of atrial cardiopathy on stroke…
Café com Journal offers updates on the latest cardiology news published in leading journals. In this session, we discuss significant findings, including a systematic review on aspirin use for primary prevention of…
RT @PBasiukiewicz: Aspiryna spełnia zarówno 1. jak i 2. kryterium, takich przykładów zresztą jest więcej. Aspiryna nawet w małej dawce zwi…
Aspiryna spełnia zarówno 1. jak i 2. kryterium, takich przykładów zresztą jest więcej. Aspiryna nawet w małej dawce zwiększa ryzyko poważnego krwawienia. Zresztą nie ma działającego leku bez działań niepożądanych. https://t.co/dh6a9cb50a
RT @CanadaRna: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Me…
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis https://t.co/UfcMnHDCv5 https://t.co/zHPaJ4y30A
Para leer con
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic... https://t.co/tncJ5fev4U
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic... https://t.co/0KDCbtZGsw
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic... https://t.co/drP8mbDn3P
RT @niihara51: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Me…
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. - PubMed - NCBI https://t.co/vQ6oUpFDDN
RT @hataboSAN: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Me…
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. https://t.co/nqaRF7jVpR
Association of #Aspirin Use for Primary Prevention With #Cardiovascular Events and Bleeding Events: https://t.co/6WfXJ6p6RJ
RT @Echoraljpangio: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding EventsA Systematic... https:/…
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding EventsA Systematic... https://t.co/xMSGzA6ykS
RT @Sefap_FAP: (SIETES) Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic revi…
(SIETES) Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis https://t.co/xsZDUypT31
RT @moisesjimenezs: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review a…
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. | Cardiology | JAMA | JAMA Network https://t.co/LPWKc6laFH
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events via @JAMANetworkOpen https://t.co/16sxT9KrI2 https://t.co/drVOkl8iBA
RT @SatrupaRagoona1: Recent #meta-analysis shows that #aspirin use in high risk and low risk groups including #diabetes reduces risk of CVD…
Recent #meta-analysis shows that #aspirin use in high risk and low risk groups including #diabetes reduces risk of CVD (NNT 265) but also increases risk of major bleeding (NNH at 210). Aspirin should not be routinely recommended in primary prevention. doi:10.1001/jama.2018.20578
RT @KSREvidence: Our #AppraisaloftheDay: A @JAMA_current #systematicreview rated at high risk of #bias. Pooled analysis reported a ⬇️risk…
RT @KSREvidence: Our #AppraisaloftheDay: A @JAMA_current #systematicreview rated at high risk of #bias. Pooled analysis reported a ⬇️risk…
Our #AppraisaloftheDay: A @JAMA_current #systematicreview rated at high risk of #bias. Pooled analysis reported a ⬇️risk of CV events but ⬆️risk of major bleeding in the prevention of #cardiovascular disease using #aspirin. Available to all for 1 day at https://t.co/k8kSLmvj4D https://t.co/pRslblXODI
Aspirin use is associated with high risk of bleeding events in patients without #Cardiovasculardisease. DOI: 10.1001/jama.2018.20578
RT @docwas: Is it time to re-visit use of Aspirin in primary prevention? Association of Aspirin Use for Primary Prevention With Cardiovascu…
Is it time to re-visit use of Aspirin in primary prevention? Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. | Cardiology | JAMA | JAMA Network https://t.co/qvA4TESpRv
Association of #Aspirin Use for Primary Prevention With #Cardiovascular Events and #Bleeding Events @JAMANetwork https://t.co/2MAWJdB9Hc
RT @NNTonthefly: New NNT→Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Rev…
"Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events" - https://t.co/SxfIgN5252 https://t.co/ewzGbnkcYe
RT @hilariobad59: @JAMA_current AAS en prevención 1 no beneficio global, < riesgo de eventos CV, pero > riesgo de sangrado y sin efecto s…
RT @hilariobad59: @JAMA_current AAS en prevención 1 no beneficio global, < riesgo de eventos CV, pero > riesgo de sangrado y sin efecto s…
RT @karacagurkan: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and…
RT @hilariobad59: @JAMA_current AAS en prevención 1 no beneficio global, < riesgo de eventos CV, pero > riesgo de sangrado y sin efecto s…
RT @hilariobad59: @JAMA_current AAS en prevención 1 no beneficio global, < riesgo de eventos CV, pero > riesgo de sangrado y sin efecto s…
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. https://t.co/xXFwdkdPvI
RT @hilariobad59: @JAMA_current AAS en prevención 1 no beneficio global, < riesgo de eventos CV, pero > riesgo de sangrado y sin efecto s…
RT @hilariobad59: @JAMA_current AAS en prevención 1 no beneficio global, < riesgo de eventos CV, pero > riesgo de sangrado y sin efecto s…
RT @hilariobad59: @JAMA_current AAS en prevención 1 no beneficio global, < riesgo de eventos CV, pero > riesgo de sangrado y sin efecto s…
RT @NNTonthefly: New NNT→Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Rev…
RT @AARONLYL: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Met…
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. | Cardiology | JAMA | JAMA Network https://t.co/u1kgbMJ0Fy
@JAMA_current AAS en prevención 1 no beneficio global, < riesgo de eventos CV, pero > riesgo de sangrado y sin efecto sobre riesgo de cáncer Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events https://t.co/yVPGMEFNCZ
Association of #Aspirin Use for Primary Prevention With #Cardiovascular Events and #Bleeding Events @JAMANetwork https://t.co/2MAWJdB9Hc
Association of #Aspirin Use for Primary Prevention With #Cardiovascular Events and #Bleeding Events @JAMANetwork https://t.co/5qyUFUr92N
RT @HematologiaMex: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review a…
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. | Cardiology | JAMA | JAMA Network https://t.co/enZraMUA3M
RT @atscommunity: Association of aspirin use for primary prevention with cardiovascular events and bleeding events: https://t.co/52QFxYK81e
Association of aspirin use for primary prevention with cardiovascular events and bleeding events: https://t.co/52QFxYK81e
RT @SophieParkUCL: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review an…
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. | Cardiology | JAMA | JAMA Network https://t.co/54HdcTVHhr
RT @NNTonthefly: New NNT→Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Rev…
New NNT→Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. https://t.co/kwmTkh1c2J
RT @OSHP_LEAD: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Me…
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis https://t.co/s8uoSW73tp
Association of #Aspirin Use for Primary Prevention With #Cardiovascular Events and #Bleeding Events @JAMANetwork https://t.co/BniaDewU14 https://t.co/mFZSQ42IP3
RT @2Scottish: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Me…
RT @2Scottish: Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Me…
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. | Cardiology | JAMA | JAMA Network. Another nail in the coffin. https://t.co/rqE1jmp5oV